产品NDC0264-2514
产品类型HUMAN PRESCRIPTION DRUG
商品名Balanced Salt
商品名后缀
通用名Sodium Chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Acetate, and Sodium Citrate
剂型SOLUTION
给药途径IRRIGATION
上市日期20100203
中止上市日期
市场分类ANDA
申请号ANDA091387
标签持有者B. Braun Medical Inc.
活性成分SODIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM ACETATE; SODIUM CITRATE
规格6.4; .75; .48; .3; 3.9; 1.7
规格单位mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL
药学分类Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
DEA N 20211231
药品包装规格及说明书信息
产品NDC NDC包装代码 包装描述 药品说明书
0264-25140264-2514-1012 BOTTLE, GLASS in 1 CASE (0264-2514-10) > 500 mL in 1 BOTTLE, GLASS 20100203 N N药品说明书及标签信息